Skip to main content
TipRanks
Go Ultimate75% OFF

Oncopeptides AB (ONCO) Cash flow

11 Followers

Oncopeptides AB Cash Flow

SE:ONCO's free cash flow for Q3 2026 was kr-37.71M. For the 2026 fiscal year, SE:ONCO's free cash flow was increased by kr0.00 and operating cash flow was kr-37.71M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
kr -222.88Mkr -260.57Mkr -279.49Mkr -420.51Mkr -1.52B
kr 0.00kr 496.00Kkr -116.00Kkr -2.51Mkr -339.00K
kr 128.55Mkr 263.81Mkr 106.89Mkr 392.40Mkr 1.03B
kr 82.25Mkr 178.54Mkr 173.41Mkr 344.51Mkr 362.19M
kr -222.88Mkr -260.57Mkr -279.61Mkr -423.02Mkr -1.52B

Currency in SEK

Oncopeptides AB Cash Flow

-2B-1.5B-1B-500M0500M1B1.5B201720182019202020212022202320242025OperatingInvestingFinancing